专栏咏竹坊

Investors pile into CANbridge stock but can the rally last?
北海康成完成1亿港元战略定增 两个半月股价飙涨逾15倍

The maker of drugs for rare diseases has enjoyed an explosive rise in its share price, helped by a partnership deal and Chinese moves to widen access to costly therapies
罕见病赛道存在患者基数天花板与支付体系瓶颈,需警惕短期估值泡沫风险。

(This article only represents the author's own views.)

(作者莫莉,本文仅代表作者个人观点)

您已阅读1%(72字),剩余99%(6297字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

咏竹坊

咏竹坊(官网链接)提供在香港和美国上市的manbetx3.0 企业相关新闻,重点关注中小企业和筹备上市的公司。

Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.

相关文章

相关话题

设置字号×
最小
较小
默认
较大
最大
分享×